7th Annual D-Town Throwdown

7th Annual D-Town Throwdown

September 16, 2019 – The seventh annual DMH CrossFit Enhance D-Town Throwdown will be held Saturday,

Sept. 21 and Sunday, Sept. 22 at the Decatur Memorial Hospital Crossfit Enhance gym located at 2122 N. 27th St., Decatur.

The D-Town Throwdown is a team-based fitness competition, comprised of teams of two males and two females and features Rx, Intermediate, Scaled, and Masters Divisions, and is renowned as one of the highest quality fitness competitions in the Midwest.

This year’s event will feature nearly 40 teams, totaling 160 athletes competing across the four divisions. During the two-day competition, the teams will have the opportunity to compete in up to eight workouts. The events range from running, to lifting weights, to high skill gymnastics, and strongman challenges, all of which will challenge the team’s physical and mental capacity, as well as how well they can work together as a team.

Admission for spectators is five dollars.

Central Illinois Community Clinical Oncology Program Receives Funding

Central Illinois Community Clinical Oncology Program Receives Funding

Decatur, Ill…Central Illinois Community Clinical Oncology Program (CICCOP) from Decatur was one of the beneficiaries of the Heartland NCORP funding from the National Cancer Institute (NCI). The Heartland Cancer Research National Community Oncology Research Program (Heartland NCORP) was formed in 2013 through the cooperative efforts of three community cancer research programs (CCOP’s); Missouri Baptist Heartland CCOP from St. Louis, Illinois Cancer Care CCOP from Peoria, Illinois and the Central Illinois CCOP from Decatur, Illinois. These three nationally recognized community cancer programs each brought to the new Heartland NCORP a strong committed network of cancer doctors, nurses, and administrators. By working together, Heartland NCORP provides state of the art National Cancer Institute supported clinical trials to 124 counties with a population of 7 million across portions of five states. Heartland NCORP serves 3/4ths of Illinois, ½ of Missouri, and the portions of Kentucky, Tennessee, and Arkansas that are adjacent to the boot heal of Missouri. This enormous region includes a large proportion of medically underserved persons who are elderly, live in rural areas, or live in inner city healthcare shortage areas. Heartland NCORP brings to cancer patients and families cutting edge research studies for cancer treatment, cancer prevention, quality of life improvement, and cancer care delivery. By combining our efforts we achieve advantages of increased efficiency and magnitude of scale, thus increasing value to the National Cancer Institute for the work we will perform.

“Decatur Memorial Hospital and Cancer Care Specialists of Illinois are proud to be a key part of the National Cancer Institute funded Heartland NCORP, said James Wade, MD, President of Cancer Care Specialists of Illinois and Director of Medical Oncology, Decatur Memorial Hospital Cancer Care Institute. This NCI six year research grant is not just given; it is awarded after an intense national competition which recognizes quality, commitment, and community impact. Our Heartland Cancer Research National Community Oncology Research Program (NCORP), one of the largest of the 32 funded programs nationally, brings state of the art therapies and improved patient outcomes to all sites we serve in Central and Southern Illinois. This new grant insures that our 35 year tradition of cancer research excellence will continue to benefit the patients and families throughout our Heartland.”

The award for the Heartland NCORP comes at the end of a long competitive process. Heartland NCORP members began planning the new program in 2013. In 2014 Heartland Cancer Research NCORP received funding for 5 years. Over 14 months ago Heartland members began writing the re-application for the cycle 2 of the NCORP grant, and submitted the completed application to the NCI last August. The grant was then evaluated and graded by a peer review committee, and in May the Heartland NCORP application received an outstanding score of 20. The NCI then subjected each successful grant to additional review, and the final award to Heartland was announced, August 16, 2019.

The NCI award of $2,755,865 per year over six years will help pay for the costs of specialized research staff who will work side by side with cancer physicians and oncology nurses. Heartland NCORP is projected to enroll more than 500 patients on NCI approved cancer clinical trials each year over the next 5 years, making it one of the largest cancer clinical research programs in the United States. By participating in a NCI approved clinical trial, patients and families can be assured that their care is delivered under the highest quality standards with special attention to each patient’s symptoms, quality of life, and cancer response to treatment.

On Friday, August 23rd, Heartland NCORP researchers were recognized with 12 awards at the National Cancer Institute in Bethesda, Maryland, for their scientific contributions over the past year. The overall Heartland NCORP received a Gold certificate for its overall success, along with two specific awards for contributing to two key NCI Cancer Care Delivery initiatives. In addition, four Decatur physicians, Jon Locke, MD, of DMH Radiology, and Drs. James Wade, Ben Esparaz, and Vijay Damarla of Cancer Care Specialists received individual recognition for their contributions to cancer research.

The Heartland NCORP grant was successful in large part due to the extensive experience and leadership of the three founding programs. The principal investigator of Heartland NCORP is Bryan A. Faller, MD, with James L. Wade III, MD, FACP, FASCO, serving as the Decatur Memorial Hospital Research Medical Director. Dr. Wade, based in Decatur, Illinois, has led the CICCOP for more than 20 years, has served on multiple NCI committees and advisory panels, and is nationally recognized and an expert in community based cancer research. He is supported by Dr. Alan Lyss of St. Louis, Dr. Jane Liu of Peoria, Dr. Justin Floyd of Swansea, Dr. Preet Singh of Springfield, and Dr. Ben Esparaz of Decatur. All of these cancer specialists bring years of experience, a desire to improve cancer care through research, and strong records in clinical trial accrual as evidenced by their multiple NCI participation awards. Dr. Wade is also supported by a seasoned administrative team from St. Louis, Decatur, and Peoria. Finally, the Heartland NCORP program would not have succeeded without the support of its component

institutions that will help underwrite the cost of the research effort. Each of these organizations recognizes that we all must do our part, and more, to help move science forward and ultimately defeat cancer. The continuation of the Heartland NCORP is another important step to that ultimate goal.

For the full list of NCORP Community Sites, Minority/Underserved Community Sites, and Research Bases, visit https://ncorp.cancer.gov/findasite For a video about NCORP, go to NCI’s YouTube page at https://youtu.be/OyCFbZYgL3U

NCORP Facts:

· From 2014-2018, approximately 30,000 patients have been enrolled in NCI clinical trials through the NCORP sites.

· From 2014-2018, over 100 clinicians and 4,500 patients have been enrolled by NCORP sites to cancer care delivery research studies.

· The NCORP encompasses 1,000+ sites across the United States.

· NCORP brings cancer research across the country, including the states of Hawaii and Alaska, and the U.S. territories of Puerto Rico, and Guam.

· Over 9,000 Doctors, Nurses, & Research Staff take part in cancer research through the NCORP sites.

· About 25% of cancer clinical trial participants from all NCORP sites are minorities.

· NCORP brings access to cancer clinical trials to communities across the United States, including in 25 states with large rural populations (based upon the 2010 U.S. Census).

o States with 30-61% rural populations: Alabama, Alaska, Arkansas, Iowa, Kentucky, Maine, Mississippi, Missouri, Montana, North Carolina, North Dakota, South Carolina, South Dakota, Tennessee, Wisconsin, Wyoming

o States with 25-29% rural populations: Georgia, Idaho, Indiana, Kansas, Nebraska, Louisiana, Minnesota, Michigan, Virginia

DMH Receives Heart Association/ Stroke Association Honor

DMH Receives Heart Association/ Stroke Association Honor

August 14, 2019 – Decatur Memorial Hospital has received an honor from the American Heart Association and American Stroke Association with a Gold Plus Achievement Award.  The award recognizes a commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.  DMH additionally received the association’s Target: Stroke SM Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. 

DMH Receives Get With the Guidelines Target: Stroke Honor

DMH Receives Get With the Guidelines Target: Stroke Honor

Decatur Memorial Hospital has received the American Heart Association/American Stroke Association’s Get With The Guidelines® Target: Stroke Honor Roll Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.

DMH earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.

“Decatur Memorial Hospital is dedicated to improving the quality of care for our stroke patients by implementing the American Heart Association’s Get With the Guidelines-Stroke initiative,” said Timothy D. Stone Jr., president & CEO, Decatur Memorial Hospital. “The tools and resources provided help us track and measure our success in meeting evidenced-based clinical guidelines developed to improve patient outcomes.”

DMH additionally received the association’s Target: StrokeSM Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.

“We are pleased to recognize Decatur Memorial Hospital for their commitment to stroke care,” said Lee H. Schwamm, M.D., national chairperson of the Quality Oversight Committee and Executive Vice Chair of Neurology, Director of Acute Stroke Services, Massachusetts General Hospital, Boston, Mass. “Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates.”

According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.

DMH Medical Group Welcomes Nauman Jahangir, MD

DMH Medical Group Welcomes Nauman Jahangir, MD

August 6th, 2019 – Nauman Jahangir, MD, has joined the DMH Medical Group and is welcoming new patients at Decatur Neurosurgery Associates, 2 Memorial Drive, Suite 202, Decatur. Dr. Jahangir brings his expertise in Neurology to the DMH Medical Group after completing a Neurology Residency with Southern Illinois University School of Medicine, Springfield. He also completed an Internal Medicine Residency with Southern Illinois University School of Medicine, Springfield.

He specializes in treating neurological diseases and disorders including: strokes, seizures, headaches, tremors, memory loss, multiple sclerosis, neuropathies and blood vessel disease of the brain. Dr. Jahangir is a member of the American Academy of Neurology, American Stroke Association, American Neurological Association, American Headache Society, and American Epilepsy Society

READ: DMH Sports Medicine to Offer Sports Physicals

READ: DMH Sports Medicine to Offer Sports Physicals

July 9th, 2019 – DMH Sports Medicine will offer sports physicals to junior high and high school students in the upcoming weeks at different locations, beginning on Thursday, July 18th from 4-7pm in the DMH Classrooms. Other times and locations include;

 

Tuesday, July 23, from 3 to 5 p.m. at Meridian High School, 728 S. Wall Street, Macon;

Thursday, Aug. 8, from 10 a.m. to 1 p.m. at Eisenhower High School, 1200 S. 16th Street, Decatur

Monday, Aug. 12, from 10 a.m. to 1 p.m. at MacArthur High School, 1499 W. Grand Ave., Decatur.

 

No appointment is necessary. Cost is $25 per child, cash or check only. Students entering 9th grade are required to have a school physical. Those school physicals will be accepted in place of a sports physical.

 

DMH Sports Medicine has partnered with the Stone Thrown Forward Foundation to provide on-site EKG’s for student athletes. A short survey and physical exam will determine if the student requires an EKG Screening. This program is covered by the Stone Thrown Forward Foundation and results will be sent to the student’s primary care physician. Information packets will be available about immunizations and vaccinations. For more information, call 217-876-4979.

DMH Receives A Rating From Safety Organization

DMH Receives A Rating From Safety Organization

Friday May 17,2019 – Decatur Memorial Hospital has been awarded an ‘A’ grade from The Leapfrog Group.  The Leapfrog Group is a national nonprofit organization committed to improving health care quality and safetyThe Safety Grade assigns an ‘A’, ‘B’, ‘C’, ‘D’ or ‘F’ grade to hospitals across the country based on their performance in preventing medical errors, injuries, accidents, infections and other harms to patients in their care. 

DMH To Host Stroke Symposium

DMH To Host Stroke Symposium

April 30, 2019 – A common misconception is that strokes occur only in older adults. Although your stroke risk increases with age, a stroke can happen to anyone at any time. Decatur Memorial Hospital is holding it’s annual stroke symposium on May 9th to talk about symptoms and the future of stroke treatment as part of stroke awareness month in May.  Ahead of that, the hospital is encouraging you to know the signs of a stroke as every second counts.  DMH Brain & Stroke Center says to use the acronym B.E. F.A.S.T. to identify common stroke symptoms: B- Balance, E- Eyes, as in do they have loss or double vision. F – Face, A – Arms,  S – Speech and T – Time. If you observe any of these signs, call 9-1-1. 

DMH Receives National Award for Wound Care

DMH Receives National Award for Wound Care

April 15, 2019 – DMH’s Wound Center has been recognized with a National award for clinical excellence.  

The  Center of Distinction Award by Healogics, the nation’s largest provider of advanced wound care services was presented to DMH for outstanding clinical outcomes for twelve consecutive months, including patient satisfaction higher than 92 percent, and a minimum wound healing rate of at least 91 percent within 30 median days to heal.

There were 621 Centers eligible for the Center of Distinction award and 423 achieved the honor.